- Home
- MTEX vs CLDI Comparison
MTEX vs CLDI Comparison
Compare MTEX & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- CLDI
- Stock Information
- Founded
- MTEX 1993
- CLDI 2014
- Country
- MTEX United States
- CLDI United States
- Employees
- MTEX N/A
- CLDI N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTEX Health Care
- CLDI Health Care
- Exchange
- MTEX Nasdaq
- CLDI Nasdaq
- Market Cap
- MTEX 19.9M
- CLDI 15.7M
- IPO Year
- MTEX 1999
- CLDI N/A
- Fundamental
- Price
- MTEX $10.00
- CLDI $0.42
- Analyst Decision
- MTEX
- CLDI Strong Buy
- Analyst Count
- MTEX 0
- CLDI 2
- Target Price
- MTEX N/A
- CLDI $15.00
- AVG Volume (30 Days)
- MTEX 1.7K
- CLDI 202.2K
- Earning Date
- MTEX 05-20-2025
- CLDI 05-13-2025
- Dividend Yield
- MTEX N/A
- CLDI N/A
- EPS Growth
- MTEX N/A
- CLDI N/A
- EPS
- MTEX 1.32
- CLDI N/A
- Revenue
- MTEX $117,866,000.00
- CLDI N/A
- Revenue This Year
- MTEX N/A
- CLDI N/A
- Revenue Next Year
- MTEX N/A
- CLDI N/A
- P/E Ratio
- MTEX $7.58
- CLDI N/A
- Revenue Growth
- MTEX N/A
- CLDI N/A
- 52 Week Low
- MTEX $6.75
- CLDI $0.35
- 52 Week High
- MTEX $16.49
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- MTEX 49.29
- CLDI 32.77
- Support Level
- MTEX $9.70
- CLDI $0.46
- Resistance Level
- MTEX $11.90
- CLDI $0.51
- Average True Range (ATR)
- MTEX 0.26
- CLDI 0.05
- MACD
- MTEX -0.03
- CLDI 0.01
- Stochastic Oscillator
- MTEX 24.00
- CLDI 8.77
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.